137 related articles for article (PubMed ID: 17761781)
1. Lack of association between common polymorphisms in UGT1A9 and gene expression and activity.
Ramírez J; Liu W; Mirkov S; Desai AA; Chen P; Das S; Innocenti F; Ratain MJ
Drug Metab Dispos; 2007 Dec; 35(12):2149-53. PubMed ID: 17761781
[TBL] [Abstract][Full Text] [Related]
2. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.
Girard H; Villeneuve L; Court MH; Fortier LC; Caron P; Hao Q; von Moltke LL; Greenblatt DJ; Guillemette C
Drug Metab Dispos; 2006 Jul; 34(7):1220-8. PubMed ID: 16595709
[TBL] [Abstract][Full Text] [Related]
3. Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
Inoue K; Miura M; Satoh S; Kagaya H; Saito M; Habuchi T; Suzuki T
Ther Drug Monit; 2007 Jun; 29(3):299-304. PubMed ID: 17529886
[TBL] [Abstract][Full Text] [Related]
4. The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.
Kuypers DR; Naesens M; Vermeire S; Vanrenterghem Y
Clin Pharmacol Ther; 2005 Oct; 78(4):351-61. PubMed ID: 16198654
[TBL] [Abstract][Full Text] [Related]
5. The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.
Lévesque E; Delage R; Benoit-Biancamano MO; Caron P; Bernard O; Couture F; Guillemette C
Clin Pharmacol Ther; 2007 Mar; 81(3):392-400. PubMed ID: 17339869
[TBL] [Abstract][Full Text] [Related]
6. Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in Japanese.
Saito Y; Sai K; Maekawa K; Kaniwa N; Shirao K; Hamaguchi T; Yamamoto N; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Ohtsu A; Matsumura Y; Saijo N; Sawada J
Drug Metab Dispos; 2009 Feb; 37(2):272-6. PubMed ID: 18981166
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.
Izukawa T; Nakajima M; Fujiwara R; Yamanaka H; Fukami T; Takamiya M; Aoki Y; Ikushiro S; Sakaki T; Yokoi T
Drug Metab Dispos; 2009 Aug; 37(8):1759-68. PubMed ID: 19439486
[TBL] [Abstract][Full Text] [Related]
8. Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha.
Barbier O; Girard H; Inoue Y; Duez H; Villeneuve L; Kamiya A; Fruchart JC; Guillemette C; Gonzalez FJ; Staels B
Mol Pharmacol; 2005 Jan; 67(1):241-9. PubMed ID: 15470081
[TBL] [Abstract][Full Text] [Related]
9. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
[TBL] [Abstract][Full Text] [Related]
10. Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans.
Kato Y; Ikushiro S; Emi Y; Tamaki S; Suzuki H; Sakaki T; Yamada S; Degawa M
Drug Metab Dispos; 2008 Jan; 36(1):51-5. PubMed ID: 17908920
[TBL] [Abstract][Full Text] [Related]
11. Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients.
Sandanaraj E; Jada SR; Shu X; Lim R; Lee SC; Zhou Q; Zhou S; Goh BC; Chowbay B
Pharmacogenomics J; 2008 Jun; 8(3):174-85. PubMed ID: 17700594
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene.
Lankisch TO; Gillman TC; Erichsen TJ; Ehmer U; Kalthoff S; Freiberg N; Munzel PA; Manns MP; Strassburg CP
Arch Toxicol; 2008 Sep; 82(9):573-82. PubMed ID: 18677463
[TBL] [Abstract][Full Text] [Related]
13. Study on the association of UGT1A9 gene c.98T>C polymorphism and mycophenolic acid plasma levels in renal transplant patients.
Ruschel LR; Schmitt VM; Silva AB; Oliveira CSA; Flach K; d'Avila DO; Thiesen FV
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28613375
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen.
Wang H; Yuan L; Zeng S
Biochem Pharmacol; 2011 Dec; 82(11):1757-63. PubMed ID: 21856293
[TBL] [Abstract][Full Text] [Related]
15. Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes.
Innocenti F; Liu W; Chen P; Desai AA; Das S; Ratain MJ
Pharmacogenet Genomics; 2005 May; 15(5):295-301. PubMed ID: 15864130
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver.
Ramírez J; Mirkov S; Zhang W; Chen P; Das S; Liu W; Ratain MJ; Innocenti F
Pharmacogenomics J; 2008 Apr; 8(2):152-61. PubMed ID: 17440429
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of UGT1A genotype and haplotype with SN-38 glucuronidation in human livers.
Wang H; Bian T; Jin T; Chen Y; Lin A; Chen C
Pharmacogenomics; 2014 Apr; 15(6):785-98. PubMed ID: 24897286
[TBL] [Abstract][Full Text] [Related]
18. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
[TBL] [Abstract][Full Text] [Related]
19. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.
Villeneuve L; Girard H; Fortier LC; Gagné JF; Guillemette C
J Pharmacol Exp Ther; 2003 Oct; 307(1):117-28. PubMed ID: 12944498
[TBL] [Abstract][Full Text] [Related]
20. Promoter polymorphisms and allelic imbalance in ABCB1 expression.
Loeuillet C; Weale M; Deutsch S; Rotger M; Soranzo N; Wyniger J; Lettre G; Dupré Y; Thuillard D; Beckmann JS; Antonarakis SE; Goldstein DB; Telenti A
Pharmacogenet Genomics; 2007 Nov; 17(11):951-9. PubMed ID: 18075465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]